Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Issue 488CardiovascularType 2 Diabetes

MRI Shows Brain Atrophy in Type 2 Diabetes Patients

Patients with Type 2 diabetes have more pronounced brain atrophy and are more likely to have cerebral infarcts, a new published study suggests.


Dr. Jane S. Saczynski, of the University of Massachusetts Medical School, Worcester, and colleagues examined the association of glycemic status and magnetic resonance imaging (MRI) findings of brain pathological changes in 4,415 elderly residents of Iceland (mean age, 76 years) without dementia participating in the Age Gene/Environment Susceptibility-Reykjavik Study.

Overall, 2,327 (53%) were normoglycemic, 1,599 (36%) had impaired fasting glucose, and 489 (11%) had Type 2 diabetes.

After adjustment for demographic and cardiovascular risk factors, Type 2 diabetic patients had significantly lower total brain volume (71.5% vs. 72.2%), gray matter volume (44.9% vs. 45.1%), and white matter volume (25.3% vs. 25.7%) compared to normoglycemic subjects.

Patients with Type 2 diabetes were also more likely to have single (odds ratio 1.45) or multiple (OR 2.27) cerebral infarcts, compared to normoglycemic individuals.

Longer duration of diabetes was associated with lower percentage of total brain volume, lower percentage of gray and white matter, and higher percentage of white matter lesions, as well as with a significantly greater likelihood of having single or multiple cerebral infarcts.

In secondary analyses, use of diabetes medication and hemoglobin A1c levels were examined in relation to brain tissue volumes and the presence of cerebral infarcts. Just more than half -- 56% -- of diabetic subjects were taking either hypoglycemic medications or insulin.

Compared with diabetics who were not taking medication, patients on medication had a significantly lower percentage of total brain volume (adjusted mean percentage 70.9 vs. 72.4) and lower percentages of gray matter (44.5 vs. 45.4) and white matter (24.9 vs. 25.6) volume, according to the report.

The authors found no association between quartiles of A1c and brain tissue volumes or the presence of infarcts.

"These findings are based on cross-sectional data and should be replicated in longitudinal studies," the research team points out.

Diabetes Care Sept, 2009;32:1608-1613.




Bookmark and Share | Print | Category | Home

This article originally posted 27 September, 2009 and appeared in  Issue 488CardiovascularType 2 Diabetes

Past five issues: Issue 796 | Diabetes Clinical Mastery Series Issue 255 | Issue 795 | SGLT-2 Inhibitors Special Edition August 2015 | Diabetes Clinical Mastery Series Issue 254 |

Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?